Clinical Trial Update: Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial studying the effect of GLP-1 on insulin biosynthesis and turnover rates in type 2 diabetes was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-02-28